Skip to main content

06-28-2021 | ADA 2021 | Conference coverage | Video

SUSTAIN-FORTE: Doubling the approved semaglutide dose for people with type 2 diabetes

Juan Pablo Frías discusses whether the findings of SUSTAIN-FORTE will justify an increase in the approved maximum dose of semaglutide for people with type 2 diabetes (3:31).

EASD Annual Meeting 2021 coverage

Access all of our ongoing coverage including the latest news and expert video interviews.

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Image Credits